New study finds the prealbumin gene alone is insufficient for diagnosis of heart failure

A new multi-center study led by doctors at Boston Medical Center and Columbia University found that having a genetic variant in the prealbumin gene alone is not sufficient for diagnosis of transthyretin amyloid cardiomyopathy in older Black patients. Published in the Journal of the American Heart Association, researchers discovered that a blood test that measures the transthyretin or prealbumin protein might also be helpful in diagnosing transthyretin amyloid cardiomyopathy and could be used to trigger more definitive imaging testing.